Erez Raphael will be joined by Personify Health President Ed Liebowitz for panel discussion on the evolving digital health market, including member choice, multi-condition care, engagement and ROI NEW YORK, Nov. 20, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that Erez Raphael, the Company's Chief Executive Officer, has been invited to lead a panel discussion at the U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum 2026, being held virtually on Monday, November 23, 2026. Erez Raphael and Ed Liebowitz, President of Personify Health, a Dario channel partner, will conduct a panel discussion on the latest trends in digital health.
Extends Dario's reach to WebMD Health Services' 3,500 employers and 65 million lives covered Partnership combines WebMD ONE, a trusted engagement platform, with Dario's comprehensive AI-powered multi-condition platform and clinical care solutions to help employers, health plans and health systems translate engagement into measurable health outcomes and in-year healthcare cost savings Revenue contribution to Dario to begin in 2027 NEW YORK, Nov. 19, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced a strategic partnership with WebMD Health Services, one of the industry's leading well-being and population health organizations serving more than 3,500 employers, health plans, health systems and public sector organizations. Dario expects the partnership to begin contributing annual recurring revenue ("ARR") in 2027, including via distribution through the administrative services organization ("ASO") of a leading integrated healthcare system serving a broad network of hospitals and healthcare services.
New agreement reflects rapid adoption of recently launched Dario Women™, the Company's women's health solution addressing perimenopause and menopause The Minnesota Star Tribune expands its existing relationship with Dario to amplify cardiometabolic health outcomes with comprehensive women's health support to eligible employees beginning January 2027 Nearly 45% of Dario's current book of business is women over age 40, representing a significant opportunity to expand adoption of Dario Women across existing clients already benefitting from its multi-condition platform NEW YORK, Nov. 18, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that The Minnesota Star Tribune, the Midwest's largest news organization, has expanded its existing contract with Dario to add Dario Women™, the Company's recently launched digital health and clinical care program supporting women navigating perimenopause and menopause. The program is expected to become available to eligible employees in January 2027.
Dario Presents New Research at ISPOR Europe 2026 Validating a Biometric-Driven Approach to Estimating Healthcare Cost Savings and ROI - Consistent with Publishe
New methodology addresses critical market need for a transparent, replicable model to estimate healthcare cost savings and ROI when medical claims data are unavailable or delayed Further demonstrates Dario's economic value in support of new contract wins, contract renewals and expansion of existing customer relationships NEW YORK, Nov. 16, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced the presentation of new research at ISPOR Europe 2026, a leading international conference focused on health economics and outcomes research, held November 8–11 in Vienna, Austria. The research highlights Dario's methodology for estimating healthcare cost savings and return on investment ("ROI") based on biometric improvements achieved by members participating in digital chronic disease management programs.
DarioHealth Corp. (DRIO) Q3 2026 Earnings Call Transcript
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to a loss of $1.85 per share a year ago.
Third quarter 2026 revenue increased 6% year-over-year and 3% sequentially to $5.3 million GAAP gross margin was 59%, compared to 60% in the third quarter of 2025; non-GAAP business-to-business-to-consumer ("B2B2C") gross margin remained at approximately 80% for the 11th consecutive quarter Revenue expected to accelerate at the end of 2026 and into 2027, driven primarily by the conversion of committed annual recurring revenue ("ARR"), including new enterprise customers and multi-condition expansions, such as Dario Women™ and Dario Sleep Expanding payer relationships from digital health behavior programming to integrated clinical care and medication management: working with a national health plan customer to bring GLP-1 therapy delivery into its member marketplace Signed one of New Jersey's largest health plans, representing 1.5 million covered lives, the third state health plan signed through the Amwell channel partnership in the past 12 months Operating loss decreased by 15% year-over-year while operating expenses declined by 10% year-over-year Cash, cash equivalents and short-term deposits totaled $31.2 million as of September 30, 2026 More than 180 signed accounts across employers and health plans, with contracted and late-stage ARR of $13.1 million, more than 80% of it relates to multi-condition opportunities Conference call today, November 12, 2026 at 8:30 am ET NEW YORK, Nov. 12, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced financial results for the third quarter ended September 30, 2026. "In the second quarter of 2026, we described how Dario's business model is designed to support growth.
DarioHealth (NASDAQ: DRIO - Get Free Report) and HealthStream (NASDAQ: HSTM - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk. Earnings and Valuation This table compares DarioHealth and HealthStream"s
Mr. Palumbo to join Dario's third quarter 2026 earnings call to share the Board's view on the convergence of consumer and payer-led healthcare and chronic care management NEW YORK, Nov. 4, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that its Board of Directors (the "Board") has appointed John R. Palumbo as Chairman of the Board, effective November 3, 2026.